ABPI warns that local reimbursement decisions may increase variation in drug uptake
This article was originally published in Scrip
Executive Summary
New data show that the uptake of drugs in England approved by HTA institute, NICE, can vary dramatically from region to region. The data indicates that planned reforms of the UK's National Health Service that will further localise reimbursement could make the situation worse, warns the Association of the British Pharmaceutical Industry (ABPI).